These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 17525734)

  • 1. p140Cap protein suppresses tumour cell properties, regulating Csk and Src kinase activity.
    Di Stefano P; Damiano L; Cabodi S; Aramu S; Tordella L; Praduroux A; Piva R; Cavallo F; Forni G; Silengo L; Tarone G; Turco E; Defilippi P
    EMBO J; 2007 Jun; 26(12):2843-55. PubMed ID: 17525734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p140Cap dual regulation of E-cadherin/EGFR cross-talk and Ras signalling in tumour cell scatter and proliferation.
    Damiano L; Di Stefano P; Camacho Leal MP; Barba M; Mainiero F; Cabodi S; Tordella L; Sapino A; Castellano I; Canel M; Frame M; Turco E; Defilippi P
    Oncogene; 2010 Jun; 29(25):3677-90. PubMed ID: 20453886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mapping of p140Cap phosphorylation sites: the EPLYA and EGLYA motifs have a key role in tyrosine phosphorylation and Csk binding, and are substrates of the Abl kinase.
    Repetto D; Aramu S; Boeri Erba E; Sharma N; Grasso S; Russo I; Jensen ON; Cabodi S; Turco E; Di Stefano P; Defilippi P
    PLoS One; 2013; 8(1):e54931. PubMed ID: 23383002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Csk-binding protein (Cbp) negatively regulates epidermal growth factor-induced cell transformation by controlling Src activation.
    Jiang LQ; Feng X; Zhou W; Knyazev PG; Ullrich A; Chen Z
    Oncogene; 2006 Sep; 25(40):5495-506. PubMed ID: 16636672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of the binding of the Src homology 2 domain of Csk to tyrosine-phosphorylated proteins in the suppression and mitotic activation of c-Src.
    Sabe H; Hata A; Okada M; Nakagawa H; Hanafusa H
    Proc Natl Acad Sci U S A; 1994 Apr; 91(9):3984-8. PubMed ID: 7513429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Purification of bovine thymus cytosolic C-terminal Src kinase (CSK) and demonstration of differential efficiencies of phosphorylation and inactivation of p56lyn and pp60c-src by CSK.
    Cheng HC; Bjorge JD; Aebersold R; Fujita DJ; Wang JH
    Biochemistry; 1996 Sep; 35(36):11874-87. PubMed ID: 8794770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Csk homologous kinase, a novel signaling molecule, directly associates with the activated ErbB-2 receptor in breast cancer cells and inhibits their proliferation.
    Zrihan-Licht S; Deng B; Yarden Y; McShan G; Keydar I; Avraham H
    J Biol Chem; 1998 Feb; 273(7):4065-72. PubMed ID: 9461599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SHP-2 binds to caveolin-1 and regulates Src activity via competitive inhibition of CSK in response to H2O2 in astrocytes.
    Jo A; Park H; Lee SH; Ahn SH; Kim HJ; Park EM; Choi YH
    PLoS One; 2014; 9(3):e91582. PubMed ID: 24632723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced C-terminal Src kinase activity is correlated inversely with pp60(c-src) activity in colorectal carcinoma.
    Cam WR; Masaki T; Shiratori Y; Kato N; Ikenoue T; Okamoto M; Igarashi K; Sano T; Omata M
    Cancer; 2001 Jul; 92(1):61-70. PubMed ID: 11443610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of C-terminal Src kinase homologous kinase suppresses activation of Lyn tyrosine kinase required for VLA5-mediated Dami cell spreading.
    Hirao A; Huang XL; Suda T; Yamaguchi N
    J Biol Chem; 1998 Apr; 273(16):10004-10. PubMed ID: 9545346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of C-terminal src kinase in human colorectal cancer cell lines.
    Watanabe N; Matsuda S; Kuramochi S; Tsuzuku J; Yamamoto T; Endo K
    Jpn J Clin Oncol; 1995 Feb; 25(1):5-9. PubMed ID: 7533218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C-terminal Src kinase-mediated EPIYA phosphorylation of Pragmin creates a feed-forward C-terminal Src kinase activation loop that promotes cell motility.
    Senda Y; Murata-Kamiya N; Hatakeyama M
    Cancer Sci; 2016 Jul; 107(7):972-80. PubMed ID: 27116701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of two regions in the p140Cap adaptor protein that retain the ability to suppress tumor cell properties.
    Sharma N; Repetto D; Aramu S; Grasso S; Russo I; Fiorentino A; Mello-Grand M; Cabodi S; Singh V; Chiorino G; Turco E; Stefano PD; Defilippi P
    Am J Cancer Res; 2013; 3(3):290-301. PubMed ID: 23841028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The inhibition of SRC family kinase suppresses pancreatic cancer cell proliferation, migration, and invasion.
    Je DW; O YM; Ji YG; Cho Y; Lee DH
    Pancreas; 2014 Jul; 43(5):768-76. PubMed ID: 24763074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of Src family kinases in the developing rat brain: correlation with their regulator kinase, Csk.
    Inomata M; Takayama Y; Kiyama H; Nada S; Okada M; Nakagawa H
    J Biochem; 1994 Aug; 116(2):386-92. PubMed ID: 7529760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. C-terminal Src kinase (CSK) modulates insulin-like growth factor-I signaling through Src in 3T3-L1 differentiation.
    Sekimoto H; Boney CM
    Endocrinology; 2003 Jun; 144(6):2546-52. PubMed ID: 12746317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Csk homologous kinase associates with RAFTK/Pyk2 in breast cancer cells and negatively regulates its activation and breast cancer cell migration.
    McShan GD; Zagozdzon R; Park SY; Zrihan-Licht S; Fu Y; Avraham S; Avraham H
    Int J Oncol; 2002 Jul; 21(1):197-205. PubMed ID: 12063569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dok-R mediates attenuation of epidermal growth factor-dependent mitogen-activated protein kinase and Akt activation through processive recruitment of c-Src and Csk.
    Van Slyke P; Coll ML; Master Z; Kim H; Filmus J; Dumont DJ
    Mol Cell Biol; 2005 May; 25(9):3831-41. PubMed ID: 15831486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coordinate interactions of Csk, Src, and Syk kinases with [alpha]IIb[beta]3 initiate integrin signaling to the cytoskeleton.
    Obergfell A; Eto K; Mocsai A; Buensuceso C; Moores SL; Brugge JS; Lowell CA; Shattil SJ
    J Cell Biol; 2002 Apr; 157(2):265-75. PubMed ID: 11940607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The transmembrane adaptor Cbp/PAG1 controls the malignant potential of human non-small cell lung cancers that have c-src upregulation.
    Kanou T; Oneyama C; Kawahara K; Okimura A; Ohta M; Ikeda N; Shintani Y; Okumura M; Okada M
    Mol Cancer Res; 2011 Jan; 9(1):103-14. PubMed ID: 21156787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.